TP53 and neoplasm: Finally, knockdown of PHLDB3 led to the induction of the p53 pathway (Figs 4c–f and 8e–g), consequently the suppression of xenograft tumour growth, more apparently in p53-containing HCT116 cells than in p53-null HCT116 (Fig. 8a–d).